Cylera
Device Security PlatformsHTMwire assessment
Healthcare IoT security platform (MedCommand) with digital twin technology for agentless device profiling, threat detection, and risk management.
Key Features
- ✓ Patented digital twin creates virtual replica of each device for safe vulnerability probing
- ✓ ML-powered real-time vulnerability database updates from multiple sources
- ✓ Agentless deep packet inspection for device discovery and threat detection
- ✓ Automated risk profiling based on vulnerabilities, IOCs, device type, and clinical dependencies
- ✓ ML-powered alert reduction for efficient threat prioritization
What It Helps You Do
What Sets Them Apart
Patented digital twin approach — creates virtual replicas of medical devices for vulnerability probing without risking disruption to patient-connected equipment.
How Cylera Uses AI
HTMwire's independent read on the technology — not the vendor's marketing claim.
Uses ML for continuous vulnerability database updates, automated risk profiling that factors in clinical context, and alert reduction that prioritizes threats by likelihood and patient safety impact. Patented digital twin technology models device behavior without touching physical devices.
- ML-based monitoring. Applies machine learning to device behavior profiling and continuous vulnerability analysis for known and unknown IoMT devices.
Key Numbers
- ▪ $17M raised; $10M Series A (March 2021)
Integrations
Tags
Featured In
Trust Signals
Frequently Asked Questions
Is Cylera's device discovery passive and agentless?
Yes. Cylera states its discovery is agentless and passive, using multi-source deep packet inspection (DPI) for complete healthcare IoT discovery, categorization, inventory, and telemetry without installing agents on devices.
Who founded Cylera and when?
Cylera was founded in 2017 by Timur Ozekcin (co-founder and CEO), Javier Berciano, and Ewelina Bialkowska. The company is headquartered in New York and focuses specifically on healthcare IoT security.
How is Cylera funded?
Cylera disclosed $17M raised through its $10M Series A in March 2021, led by Concord Health Partners and Maverick Ventures, with participation from Two Sigma Ventures, Samsung NEXT, Contour Venture Partners, and others.
Does Cylera serve hospitals outside the US?
Cylera markets itself as built for hospitals and works with UK and US healthcare providers, and in 2023 partnered with Omantel to deliver healthcare IoT security in the Middle East. We could not verify specific named hospital case studies with quantified outcomes.
Sources
- SecurityWeek: Cylera closes $10M Series A ($17M total)
- Cylera healthcare discovery & inventory (agentless, passive DPI)
- FinTech Global: Cylera closes $10M Series A
We cite a primary or named source for every claim on this page. How we evaluate →